Clinical trial
A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and…
NCT00229645 · Dr Alexander McIntyre Inc., Other · Completed
Key facts
| NCT number | NCT00229645 |
|---|---|
| Title | A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety |
| Official title | A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and Tolerability of Immediate-Release Formulation of Quetiapine Fumarate as Potentiation of Selective Serotonin Reuptake Inhibitors, and Serotonin Norepinephrine Reuptake Inhibitors Treatment in Major Depression With… |
| Lead sponsor | Dr Alexander McIntyre Inc., Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depression With Comorbid Anxiety Symptoms |
| Intervention type | Drug |
| Interventions | Quetiapine Fumarate (Seroquel®) |
| Enrollment | 60 |
| Start date | Nov 1, 2003 |
| Completion | Apr 1, 2005 |
| First posted | Sep 30, 2005 |
| Last update posted | Jul 13, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: